The immunohistochemistry (IHC) results demonstrated that DYNC1H1, GTPBP4, PRKDC, RBM19, SF3B4, SPATS2 and TAF9 were significantly increased in HCC tumor cells compared to normal hepatocytes (Figures 9, 10). The gene discussed is SPATS2; the disease is hepatocellular carcinoma.